Clinical Trial Update: Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating carboplatin-paclitaxel-pembrolizumab as neoadjuvant therapy for locally advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Carboplatin-Paclitaxel-Pembrolizumab

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Locally Advanced Cervical Cancer | Phase 2 | Status: UNKNOWN